Skip to main content
. 2019 Oct 21;8(12):e1677139. doi: 10.1080/2162402X.2019.1677139

Figure 1.

Figure 1.

Kaplan–Meier curves for 3-year melanoma-specific death in patients with melanoma of unknown primary (MUP) and melanoma with known primary MKP) who underwent treatment with immune checkpoint inhibitors. Log-rank test was statistically significant (P = .0112) with a hazard ratio for MUP patients of 0.29 (95% confidence interval of 0.11 to 0.75).